Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols
combine treatments.
5,100+ studies for
112 treatments. c19early.org
|
risk of death, 42.8% lower, HR 0.57, p = 0.005, high D levels (≥20 ng/mL) 8,300, low D levels (<20 ng/mL) 8,300, inverted to make HR<1 favor high D levels (≥20 ng/mL), propensity score matching.
|
risk of hospitalization, 18.7% lower, HR 0.81, p < 0.001, high D levels (≥20 ng/mL) 8,300, low D levels (<20 ng/mL) 8,300, inverted to make HR<1 favor high D levels (≥20 ng/mL), propensity score matching.
|
ER visit, 10.2% lower, HR 0.90, p = 0.03, high D levels (≥20 ng/mL) 8,300, low D levels (<20 ng/mL) 8,300, inverted to make HR<1 favor high D levels (≥20 ng/mL), propensity score matching.
|
risk of PASC, 2.0% higher, HR 1.02, p = 0.93, high D levels (≥20 ng/mL) 8,300, low D levels (<20 ng/mL) 8,300, inverted to make HR<1 favor high D levels (≥20 ng/mL), propensity score matching.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |